PHI with Regional ileocolitis
How does this condition affect your private health insurance?
Ileocolitis regionalis, commonly known as Crohn's disease affecting the ileum and colon, is a chronic inflammatory bowel disease. It's characterized by transmural inflammation, meaning it affects all layers of the intestinal wall, often in a patchy, discontinuous pattern. Symptoms include severe abdominal pain, persistent diarrhea (sometimes bloody), weight loss, fatigue, and fever. Complications can range from intestinal obstructions, fistulas, and abscesses to malnutrition and an increased risk of colorectal cancer. While its exact cause remains unknown, it's believed to involve a combination of genetic predisposition, immune system dysfunction, and environmental factors. Treatment aims to manage symptoms, reduce inflammation, and prevent complications, but there is currently no cure, making it a lifelong condition.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 60%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for an initial flare-up
Duration of Illness (Lifetime)
Chronic, lifelong condition with periods of remission and relapse
Cost of Treatment (Initial)
High (e.g., $5,000 - $30,000+ for diagnostics, medications, and potential hospitalization)
Cost of Treatment (Lifetime)
Very High (e.g., $20,000 - $50,000+ annually, lifelong management)
Mortality Rate
Low directly from the disease itself; complications like severe infection or perforation can be fatal (<5% over 10 years for uncomplicated cases)
Risk of Secondary Damages
High (>50% will experience complications like strictures, fistulas, abscesses, or need surgery; significant risk of malnutrition, joint pain, skin/eye manifestations)
Probability of Full Recovery
Very low (<5%), as it is a chronic, relapsing condition; remission is achievable but not a cure without consequences
Underlying Disease Risk
Moderate to High (e.g., 20-40% for extra-intestinal manifestations like arthritis, skin conditions, eye inflammation; increased risk for osteoporosis)